TGF-β1

Atomized paclitaxel liposome inhalation treatment of bleomycin-induced pulmonary fibrosis in rats

Y. Zhou, Zhu, W. P., Cai, X. J., Chen, M., Zhou, Y., Zhu, W. P., Cai, X. J., Chen, M., Zhou, Y., Zhu, W. P., Cai, X. J., and Chen, M., “Atomized paclitaxel liposome inhalation treatment of bleomycin-induced pulmonary fibrosis in rats”, vol. 15, p. -, 2016.

We sought to determine the efficacy of atomized paclitaxel liposome inhalation treatment of pulmonary fibrosis in a bleomycin-induced rat model. Forty male Sprague-Dawley rats were randomly divided into four groups: healthy control, pulmonary fibrosis without treatment, paclitaxel liposome inhalation-treated, and intravenous paclitaxel liposome-treated. Fibrosis was induced by bleomycin injection. A total of 20 mg/kg paclitaxel liposome was administered by inhalation every other day for a total of 10 doses.

TGF-β1 and Serpine 1 expression changes in traumatic deep vein thrombosis

J. W. Mo, Zhang, D. F., Ji, G. L., Liu, X. Z., and Fan, B., “TGF-β1 and Serpine 1 expression changes in traumatic deep vein thrombosis”, vol. 14, pp. 13835-13842, 2015.

The objective of this study was to investigate the expression changes of transforming growth factor β1 (TGF-β1) and Serpine 1 in rats with traumatic deep vein thrombosis (DVT). In total, 60 male Sprague Dawley rats were divided into model (N = 50) and control groups (Group A, N = 10).

Subscribe to TGF-β1